Study Details

Back
Study ID 40601/NCT4
Study Title Post-Marketing Clinical Study of Ramosetron Hydrochloride (Nasea® 0.3-mg Injection) - Multicenter, Double-Blind, Parallel-Group Comparative Study of Ramosetron Hydrochloride versus Ondansetron Hydrochloride(Original language of CSR synopsis is Japanese.)
Clinicaltrials.gov Identifier Not Applicable
Compound Name YM060 / ramosetron hydrochloride
Medical Indication or Disease Antineoplastic drug-induced nausea and vomiting
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date Jun-2004
Study Completion Date Jun-2005
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS